CHEK1 and breast carcinoma: Debromohymenialdisine (DBH), isolated from Stylissa flabeliformis, is a potent inhibitor against Chk1 and Chk2, without effect on ATM or ATR in human breast cancer cells with a dominant negative mutant 53-defective.